Company / Current Assets
Ventyx Biosciences, Inc. Current Assets History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$229.6M
FY2024
5-year range
$245.0K / $330.7M
FY2020-FY2024
Trend
-13.1%
vs FY2023
Sector context
#175 of 214
Health Care
What the data says
Ventyx Biosciences, Inc.'s current assets of $230M is lower than 82% of companies in the Health Care sector (FY2024). Declined from $331M to $230M over the past 2 years.
Based on SEC 10-K filings.
$230M in FY2024 with a 3-year CAGR of -4.4%.
Declined from $331M to $230M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -4.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 214This company $229.6M Sector average $2.5B
▼
-90.9% below sector average
Key checks
Key Insights
- 3-year CAGR of -4.4%, indicating a declining trend.
- In FY2024, current assets decreased 13.1% year-over-year.
- Ranks #175 out of 214 companies in the Health Care sector.
- Peak current assets was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 3.63 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $229.6M | -13.1% |
| FY2023 | $264.3M | -20.1% |
| FY2022 | $330.7M | +25.7% |
| FY2021 | $263.0M | +107255.1% |
| FY2020 | $245.0K | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026